Stereotactic body radiation vs. intensity-modulated radiation for unresectable pancreatic cancer.

MLA

Park, Joseph J., et al. “Stereotactic Body Radiation vs. Intensity-Modulated Radiation for Unresectable Pancreatic Cancer.” Acta Oncologica (Stockholm, Sweden), vol. 56, no. 12, Dec. 2017, pp. 1746–53. EBSCOhost, https://doi.org/10.1080/0284186X.2017.1342863.

APA

Park, J. J., Hajj, C., Reyngold, M., Shi, W., Zhang, Z., Cuaron, J. J., Crane, C. H., O’Reilly, E. M., Lowery, M. A., Yu, K. H., Goodman, K. A., & Wu, A. J. (2017). Stereotactic body radiation vs. intensity-modulated radiation for unresectable pancreatic cancer. Acta Oncologica (Stockholm, Sweden), 56(12), 1746–1753. https://doi.org/10.1080/0284186X.2017.1342863

Chicago

Park, Joseph J, Carla Hajj, Marsha Reyngold, Weiji Shi, Zhigang Zhang, John J Cuaron, Christopher H Crane, et al. 2017. “Stereotactic Body Radiation vs. Intensity-Modulated Radiation for Unresectable Pancreatic Cancer.” Acta Oncologica (Stockholm, Sweden) 56 (12): 1746–53. doi:10.1080/0284186X.2017.1342863.